COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience

Michela M Fabricius1, Dima Dandachi2

  • 1Medical Student, University of Missouri-Columbia, Columbia, Missouri.

Missouri Medicine
|February 8, 2021
PubMed

Insights

Convalescent plasma, an established therapy, was investigated for treating coronavirus disease 2019 (COVID-19). This study reviews existing research and details establishing a plasma donation program for COVID-19 patients.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Hematology

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic necessitated exploring novel and repurposed therapeutic strategies.
  • Convalescent plasma, derived from recovered patients, has a history of use in treating viral infections.
  • The efficacy and implementation of convalescent plasma for COVID-19 required thorough investigation.

Purpose of the Study:

  • To systematically review current research on convalescent plasma as a treatment for COVID-19.
  • To describe the practical experience of creating and managing a single-center convalescent plasma donation program.

Main Methods:

  • A systematic literature review was conducted to synthesize existing studies on convalescent plasma for COVID-19.
  • The establishment of a convalescent plasma donation program was detailed, outlining operational aspects.

Main Results:

  • The systematic review summarized the available evidence regarding convalescent plasma therapy in COVID-19 patients.
  • The description of the donation program provided insights into logistical and operational considerations.

Conclusions:

  • Convalescent plasma emerged as a potential therapeutic option during the COVID-19 pandemic.
  • The establishment of donation programs is crucial for facilitating the use of convalescent plasma in clinical settings.